IP Library Granted Patent US 8,809,045
Granted Patent B2
US 8,809,045 · App. 12/307,879 · Granted Aug 19, 2014

Human artificial chromosome (HAC) vector and human cell medicine comprising same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,809,045
App. No.
12/307,879
Granted
Aug 19, 2014
Kind
B2
Abstract

This invention relates to a human artificial chromosome (HAC) vector carrying a human chromosome-derived centromere, a subtelomere sequence, and a telomere sequence, to a human cell medicine or human cells comprising the HAC vector, to methods for preparing the HAC vector and human cells, and to methods for producing a therapeutic protein using the HAC vector.

Claims (32)

1. A human artificial chromosome (HAC) vector comprising a human chromosome 14 fragment with deletion of a long-arm distal region at AL391156, wherein the human chromosome 14 fragment comprises a human chromosome 14-derived centromere, a telomere sequence, and a subtelomere sequence,

wherein the telomere sequence and the subtelomere sequence represent a region from a site within the 14q32 region to the 14q-tel region of human chromosome 14 and are added to the long-arm distal region that is deleted, and wherein the subtelomere sequence is approximately 5 to 60 Kb.

2. The HAC vector according to claim 1 , wherein the human chromosome 14 fragment has a size of approximately 19 Mb or smaller.

3. The HAC vector according to claim 1 , wherein said HAC vector further comprises a foreign DNA encoding a protein.

4. The HAC vector according to claim 3 , wherein the foreign DNA is inserted into a more proximal region than the position where the long-arm distal region is deleted from the human chromosome 14 fragment.

5. The HAC vector according to claim 3 , wherein the foreign DNA is inserted into a region 1 to 500 kb away from the telomere sequence.

6. The HAC vector according to claim 1 , wherein the human chromosome 14 fragment further comprises the short-arm of human chromosome 14.

7. The HAC vector according to claim 1 , wherein the human chromosome 14 fragment lacks the short-arm distal region due to deletion and comprises a short-arm proximal region of human chromosome 14.

8. The HAC vector according to claim 1 , wherein the human chromosome 14 fragment lacks the long-arm and short-arm distal regions due to deletion and comprises long-arm and short-arm proximal regions of human chromosome 14.

9. The HAC vector according to claim 1 , wherein the short-arm distal region of the human chromosome 14 fragment is deleted within the p11 region or between the p11 region and the p12 region of the short arm of human chromosome 14.

10. The HAC vector according to claim 1 , wherein the human chromosome 14 fragment further comprises: (iv) at least one recognition site for a site-directed recombinant enzyme.

11. The HAC vector according to claim 10 , wherein the human chromosome 14 fragment comprises at least two types of recognition sites for site-directed recombinant enzymes.

12. The HAC vector according to claim 10 , wherein the recognition site for the site-directed recombinant enzyme is inserted into the long-arm proximal region and/or the short-arm proximal region of the human chromosome 14 fragment.

13. The HAC vector according to claim 10 , wherein the site-directed recombinant enzyme is the enzyme Cre, and the recognition site for the site-directed recombinant enzyme is the loxP sequence.

14. The HAC vector according to claim 10 , wherein the site-directed recombinant enzyme is the FLPe enzyme, and the recognition site for the site-directed recombinant enzyme is the FRT sequence.

15. A method for preparing a human artificial chromosome (HAC) vector containing foreign DNA, comprising the following steps:

(a) obtaining a cell that carries a human chromosome 14 or a human chromosome 14 fragment;

(b) deleting the long-arm distal region of the human chromosome 14 or the human chromosome 14 fragment;

(c) adding a telomere sequence or a telomere sequence in combination with a subtelomere sequence at a site(s) where the long-arm region is deleted;

(d) inserting at least one recognition site for a site-directed recombinant enzyme into the human chromosome 14 or the human chromosome 14 fragment; and

(e) inserting foreign DNA into the human chromosome 14 or the human chromosome 14 fragment in the presence of a site-directed recombinant enzyme,

wherein the deletion in step (b) is deletion of a long-arm distal region at AL391156, wherein the telomere sequence and the subtelomere sequence represent a region from a site within the 14q32 region to the 14q-tel region of human chromosome 14 and are added to the long-arm distal region that is deleted, and wherein the subtelomere sequence is approximately 5 to 60 Kb.

16. A method for preparing a human artificial chromosome (HAC) vector containing foreign DNA, comprising the following steps:

(a) obtaining a cell that carries a human chromosome 14 or a human chromosome 14 fragment;

(b) deleting the long-arm distal region of the human chromosome 14 or the human chromosome 14 fragment;

(c) adding a telomere sequence or a telomere sequence in combination with a subtelomere sequence at a site(s) where the long-arm region is deleted;

(d) inserting at least two types of recognition sites for site-directed recombinant enzymes into the human chromosome 14 or the human chromosome 14 fragment;

(e) inserting foreign DNA comprising a drug-resistance gene expression unit or fragment thereof into the human chromosome 14 or the human chromosome 14 fragment in the presence of a site-directed recombinant enzyme; and

(f) removing said drug-resistance gene expression unit or fragment thereof from the human chromosome 14 or the human chromosome 14 fragment in the presence of a site-directed recombinant enzyme different from the recombinant enzyme used in step (e),

wherein the deletion in step (b) is deletion of a long-arm distal region at AL391156, wherein the telomere sequence and the subtelomere sequence represent a region from a site within the 14q32 region to the 14q-tel region of human chromosome 14 and are added to the long-arm distal region that is deleted, and wherein the subtelomere sequence is approximately 5 to 60 Kb.

17. The method according to claim 16 , wherein the drug-resistant gene is a neomycin-resistant gene.

18. A HAC vector containing a foreign DNA, which is obtained by the method according to claim 15 .

Assignments (2)
CHANGE OF NAME AND ADDRESS Recorded Oct 23, 2019
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA KIRIN CO., LTD.
Reel/Frame 050797/0533 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2009
From: KAKEDA, MINORU; TOMIZUKA, KAZUMA; OSHIMURA, MITSUO; KAZUKI, YASUHIRO
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 022897/0647 →